Novel role for aldose reductase in mediating acute inflammatory responses in the lung

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 8128-8137

  Ravindranath, Thyyar M ^a   Mong, Phyllus Y ^a,b   Ananthakrishnan, Radha ^a   Li, Qing ^a   Quadri, Nosirudeen ^a   Schmidt, Ann Marie ^a   Ramasamy, Ravichandran ^a   Wang, Qin ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; CD11B ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; RHO KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; BIOACCUMULATION; CELL ADHESION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; EXPERIMENTAL LIGATION; HUMAN; HUMAN CELL; LUNG ENDOTHELIUM; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY BURST; TRANSGENIC MOUSE; WILD TYPE; ACUTE LUNG INJURY; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CECUM; CELL CULTURE; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LIGATION; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; PUNCTURE; SEPSIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ACUTE LUNG INJURY; ADJUVANTS, IMMUNOLOGIC; ALDEHYDE REDUCTASE; ANIMALS; CECUM; CELL ADHESION; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; LIGATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHIL INFILTRATION; PUNCTURES; SEPSIS; SIGNAL TRANSDUCTION;

EID: 76249091677     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900720     Document Type: Article

References (45)

1. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
2. Matthay, M. A., and G. A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am. J. Respir. Cell Mol. Biol. 33: 319-327.
3. Harrison, D. H., K. M. Bohren, D. Ringe, G. A. Petsko, and K. H. Gabbay. 1994. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate. Biochemistry 33: 2011-2020.
4. Grimshaw, C. E., K. M. Bohren, C. J. Lai, and K. H. Gabbay. 1995. Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition. Biochemistry 34: 14374-14384.
5. Cumbie, B. C., and K. L. Hermayer. 2007. Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc. Health Risk Manag. 3: 823-832.
6. Ananthakrishnan, R., M. Kaneko, Y. C. Hwang, T. Gomes, C. Caspersen, and R. Ramasamy. 2009. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. Am J. Physiol. 296: H333-H341.
7. Ho, E. C., K. S. Lam, Y. S. Chen, J. C. Yip, M. Arvindakshan, S. Yamagishi, S. Yagihashi, P. J. Oates, C. A. Ellery, S. S. Chung, and S. K. Chung. 2006. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 55: 1946-1953.
8. Kaneko, M., L. Bucciarelli, Y. C. Hwang, L. Lee, S. F. Yan, A. M. Schmidt, and R. Ramasamy. 2005. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Ann. NY Acad. Sci. 1043: 702-709. (Pubitemid 41123963)
9. Vikramadithyan, R. K., Y. Hu, H. L. Noh, C. P. Liang, K. Hallam, A. R. Tall, R. Ramasamy, and I. J. Goldberg. 2005. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J. Clin. Invest. 115: 2434-2443.
10. Hwang, Y. C., M. Kaneko, S. Bakr, H. Liao, Y. Lu, E. R. Lewis, S. Yan, S. Ii, M. Itakura, L. Rui, et al. 2004. Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J. 18: 1192-1199.
11. Ramana, K. V., M. S. Willis, M. D. White, J. W. Horton, J. M. DiMaio, D. Srivastava, A. Bhatnagar, and S. K. Srivastava. 2006. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 114: 1838-1846.
12. Mong, P. Y., C. Petrulio, H. L. Kaufman, and Q. Wang. 2008. Activation of Rho kinase by TNF-α is required for JNK activation in human pulmonary microvascular endothelial cells. J. Immunol. 180: 550-558.
13. Kamata, H., S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin. 2005. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661. (Pubitemid 40343077)
14. Pham, C. G., C. Bubici, F. Zazzeroni, S. Papa, J. Jones, K. Alvarez, S. Jayawardena, E. De Smaele, R. Cong, C. Beaumont, et al. 2004. Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542.
15. Sakon, S., X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, Y. Kojima, J. H. Piao, H. Yagita, K. Okumura, T. Doi, and H. Nakano. 2003. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22: 3898-3909.
16. 2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23: 2871-2882.
17. Baker, C. I., H. O. Gaines, and A. E. Baue. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94: 331-335.
18. Mong, P. Y., and Q. Wang. 2009. Activation of Rho kinase isoforms in lung endothelial cells during inflammation. J. Immunol. 182: 2385-2394.
19. Goodman, E. B., D. C. Anderson, and A. J. Tenner. 1995. C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J. Leukocyte Biol. 58: 168-176.
20. Heuer, J. G., D. L. Bailey, G. R. Sharma, T. Zhang, C. Ding, A. Ford, E. J. Stephens, K. C. Holmes, R. L. Grubbs, K. A. Fynboe, et al. 2004. Cecal ligation and puncture with total parenteral nutrition: a clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness. J. Surg. Res. 121: 178-186.
21. Christopher, M. J., and D. C. Link. 2007. Regulation of neutrophil homeostasis. Curr. Opin. Hematol. 14: 3-8.
22. Ueda, Y., M. Kondo, and G. Kelsoe. 2005. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201: 1771-1780. (Pubitemid 41002896)
23. Doerschuk, C. M. 2001. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8: 71-88.
24. Tasaka, S., H. Koh, W. Yamada, M. Shimizu, Y. Ogawa, N. Hasegawa, K. Yamaguchi, Y. Ishii, S. E. Richer, C. M. Doerschuk, and A. Ishizaka. 2005. Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632. Am. J. Respir. Cell Mol. Biol. 32: 504-510.
25. Loirand, G., P. Guerin, and P. Pacaud. 2006. Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 98: 322-334. (Pubitemid 43755328)
26. 2 (Mac-1) on neutrophil-derived microparticles. Blood 112: 2327-2335.
27. Takahashi, T., F. Hato, T. Yamane, H. Fukumasu, K. Suzuki, S. Ogita, Y. Nishizawa, and S. Kitagawa. 2001. Activation of human neutrophil by cytokine-activated endothelial cells. Circ. Res. 88: 422-429. (Pubitemid 32200116)
28. Kaiserova, K., X. L. Tang, S. Srivastava, and A. Bhatnagar. 2008. Role of nitric oxide in regulating aldose reductase activation in the ischemic heart. J. Biol. Chem. 283: 9101-9112.
29. Riedemann, N. C., T. A. Neff, R. F. Guo, K. D. Bernacki, I. J. Laudes, J. V. Sarma, J. D. Lambris, and P. A. Ward. 2003. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J. Immunol. 170: 503-507.
30. Calandra, T., J. Gerain, D. Heumann, J. D. Baumgartner, and M. P. Glauser. 1991. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines: the Swiss-Dutch J5 Immunoglobulin Study Group. Am. J. Med. 91: 23-33.
31. Remick, D. G., G. Bolgos, S. Copeland, and J. Siddiqui. 2005. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect. Immun. 73: 2751-2757. (Pubitemid 40570341)
32. van Eeden, S. F., Y. Kitagawa, M. E. Klut, E. Lawrence, and J. C. Hogg. 1997. Polymorphonuclear leukocytes released from the bone marrow preferentially sequester in lung microvessels. Microcirculation 4: 369-380. (Pubitemid 127674019)
33. Prescott, S. M., G. A. Zimmerman, and T. M. Mclntyre. 1984. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc. Natl. Acad. Sci. USA 81: 3534-3538.
34. Bussolino, F., G. Camussi, and C. Baglioni. 1988. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1a. J. Biol. Chem. 263: 11856-11861.
35. Fahmy, R. G., A. Waldman, G. Zhang, A. Mitchell, N. Tedla, H. Cai, C. R. Geczy, C. N. Chesterman, M. Perry, and L. M. Khachigian. 2006. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat. Biotechnol. 24: 856-863. (Pubitemid 44086629)
36. Arndt, P. G., S. K. Young, J. G. Lieber, M. B. Fessler, J. A. Nick, and G. S. Worthen. 2005. Inhibition of c-Jun N-terminal kinase limits lipopolysaccharide-induced pulmonary neutrophil influx. Am. J. Respir. Crit. Care Med. 171: 978-986.
37. El-Remessy, A. B., G. Abou-Mohamed, R. W. Caldwell, and R. B. Caldwell. 2003. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest. Ophthalmol. Vis. Sci. 44: 3135-3143.
38. 2 mediation. Am. J. Physiol. 293: H3096-H3104.
39. Tang, W. H., S. Wu, T. M. Wong, S. K. Chung, and S. S. Chung. 2008. Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart. Free Radical Biol. Med. 45: 602-610.
40. Dale, D. C., L. Boxer, and W. C. Liles. 2008. The phagocytes: neutrophils and monocytes. Blood 112: 935-945.
41. Kim, S. Y., A. D. Nguyen, J. L. Gao, P. M. Murphy, B. C. Mansfield, and J. Y. Chou. 2006. Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions. J. Biol. Chem. 281: 28794-28801.
42. Kim, S. Y., H. S. Jun, P. A. Mead, B. C. Mansfield, and J. Y. Chou. 2008. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood 111: 5704-5711.
43. Cheung, Y. Y., S. Y. Kim, W. H. Yiu, C. J. Pan, H. S. Jun, R. A. Ruef, E. J. Lee, H. Westphal, B. C. Mansfield, and J. Y. Chou. 2007. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-β. J. Clin. Invest. 117: 784-893.
44. Kummer, U., J. Zobeley, J. C. Brasen, R. Fahmy, A. L. Kindzelskii, A. R. Petty, A. J. Clark, and H. R. Petty. 2007. Elevated glucose concentrations promote receptor-independent activation of adherent human neutrophils: an experimental and computational approach. Biophys. J. 92: 2597-2607. (Pubitemid 46536439)
45. Olsen, L. F., U. Kummer, A. L. Kindzelskii, and H. R. Petty. 2003. A model of the oscillatory metabolism of activated neutrophils. Biophys. J. 84: 69-81.